小肝细胞癌射频消融术后推荐的10年随访策略:成本效果评价
本研究从全球机构收集11243例患者计算复发率,建立覆盖10年的马尔可夫模型,比较25种涉及CT、MRI或超声联合甲胎蛋白及3或6个月间隔的监测策略。基础分析中,前2年每3个月CT、之后每6个月CT、5年后转为每半年超声联合甲胎蛋白为优势策略,与不随访相比ICER为68570.92美元。
要点
- 小肝细胞癌射频消融术后推荐前2年每3个月CT、之后每6个月CT。
- 5年后转为每半年超声筛查联合甲胎蛋白检测。
核心结论
- 对于小肝细胞癌射频消融术后患者,推荐随访策略为前2年每3个月CT、之后每6个月CT、5年后转为每半年超声筛查联合甲胎蛋白检测。
研究设计与样本
- 从全球机构收集11243例患者计算复发率,建立覆盖10年期的马尔可夫模型,比较25种监测策略。
主要发现
- 基础分析中,优势策略为前2年每3个月CT、之后每6个月CT、5年后转为每半年超声筛查联合甲胎蛋白检测(m3_CT-m6_CT-m6_USAFP),与不随访策略相比ICER为68570.92美元。
- 单因素敏感性分析显示ICER始终低于100000.00美元支付意愿阈值。
- 概率敏感性分析中,m3_CT-m6_CT-m6_USAFP在95.6%的模拟场景中具成本效果。
关键数值与推荐
- 推荐策略:前2年每3个月CT,之后每6个月CT,5年后转为每半年超声筛查联合甲胎蛋白检测。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: An optimal follow-up schedule for small (≤3-cm) hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) remains unclear in clinical guidelines. We aimed to assess the cost-effectiveness of follow-up strategies in patients with small HCC after RFA. METHODS: In total, 11,243 patients were collected from global institutions to calculate recurrence rates. Subsequently, a Markov model covering a 10-year period was developed to compare 25 surveillance strategies involving different surveillance techniques (computed tomography [CT], magnetic resonance imaging or ultrasonography [US], and α-fetoprotein [AFP]) and intervals (3 or 6 months). The study endpoint was incremental cost-effectiveness ratio (ICER), which represented additional cost per incremental quality-adjusted life year. Sensitivity analysis was conducted by varying the values of input parameters to observe the ICER. RESULTS: In a base case analysis, the dominant strategy was CT every 3 months during an initial 2 years, followed by semiannual CT, and then switch to biannual the combination of US screening and AFP testing after 5 years (m3_CT-m6_CT-m6_USAFP), with an ICER of $68,570.92 compared with the "not followed" strategy. One-way sensitivity analysis showed the ICER consistently remained below the willingness-to-pay threshold of $100,000.00. In a probabilistic sensitivity analysis, m3_CT-m6_CT-m6_USAFP was the most cost-effective approach in 95.6% of simulated scenarios at a willingness-to-pay threshold. DISCUSSION: For small HCC after RFA, the recommended follow-up strategy is CT, with scans scheduled every 3 months for the first 2 years, every 6 months thereafter, and transition to biannual the combination of US screening and AFP testing after 5 years.
引用
- Chen QF, Chen S, Yi JZ, et al. Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation. Am J Gastroenterol. 2024. PMID: 38526213. doi:10.14309/ajg.0000000000002774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。